Uterine artery embolization in residual arterio-venous fistula due to invasive mole using glue and polyvinyl alcohol particles: Case report

Kishor Taori, Jawahar Rathod, Amit Disawal, Anand Hatgaonkar, Suresh Dhakate, Ramesh Parate, Shyam Chhadi, Vishal Bakare, Prasad Wavare, Rakhi Puria

Department of Radio-Diagnosis, Government Medical College and Hospital, Nagpur, India.

DOI: 10.4236/ojog.2013.31006                

Abstract

Gestational trophoblastic diseases (GTD) are one of the rare complications of pregnancy, which include partial and complete moles with their more aggressive counterparts termed as Gestational trophoblastic neoplasias (GTN). Their association with uterine vascular malformations is well recognised and should be suspected in appropriate clinical settings. Selective uterine artery embolization is a safe and effective alternative method of treatment in a patient with severe per vaginal bleeding from residual uterine vascular malformations due to GTN which has relative lower morbidity and mortality than surgical procedures. Here, we report a case of residual uterine arterio-venous malformation due to invasive mole detected by ultrasonography (US) and contrast enhancedMRI & referred to Interventional Radiology for Transcathetor arterial embolization.

Keywords

Gestational Trophoblastic Diseases and Neoplasias; Glue; Polyvinyl Alcohol Particles; Selective Uterine Artery Embolization; Vascular Malformation

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Lim, A.K.P., Agarwal, R., Seckl, M.J., Newlands, E.S., Barrett, N.K. and Mitchell, A.W.M. (2000) Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors. RSNA Scientific Assembly.
[2]	Bagshawe, K.D., Dent, J. and Webb, J. (1986) Hydatidiform mole in England and Wales 1973-1983. Lancet, 2, 673-677. doi:10.1016/S0140-6736(86)90179-0
[3]	Bagshawe, K.D., Dent, J., Newlands, E.S., Begent, R.H. and Rustin, G.J. (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). British Journal of Obstetrics and Gynaecology, 96, 795-802. doi:10.1111/j.1471-0528.1989.tb03318.x
[4]	Newlands, E.S., Bagshawe, K.D., Begent, R.H.J., Rustin, G.J.S., Holden, L. and Dent, J. (1986) Developments in chemotherapy for medium and high risk patients with gestational trophoblastic tumours. British Journal of Obstetrics and Gynaecology, 93, 63-69.
[5]	Lurain, J.R. (1990) Gestational trophoblastic tumors. Seminars in Surgical Oncology, 6, 347-353. doi:10.1002/ssu.2980060610
[6]	Soto-Wright, V., Berstein, M., Goldstein, D.P. and Berkowitz, R.S. (1995) The changing clinical presentation of complete molar pregnancy. Obstetrics and Gynaecology, 86, 775-779. doi:10.1016/0029-7844(95)00268-V
[7]	Sebire, N.J., Rees, H., Paradinas, F., Seck, M. and Newlands, E.S. (2001) The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound in Obstetrics & Gynecology, 18, 662-665.
[8]	Fowler, D.J., Lindsay, I., Seck, M.J. and Sebire, N.J. (2006) Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: Experience of more than 1000 cases from a regional referral center. Ultrasound in Obstetrics & Gynecology, 27, 56-60. doi:10.1002/uog.2592
[9]	Johns, J., Greenwold, N., Buckley, S. and Jauniaux, E. (2005) A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound in Obstetrics & Gynecology, 25, 493-497. doi:10.1002/uog.1888
[10]	Feltmate, C.M., Genest, D.R., Goldstein, D.P., et al. (2002) Advances in the understanding of placental site trophoblastic tumor. Journal of Reproductive Medicine, 47, 337-341.
[11]	Schmid, P., Nagai, Y., Agarwa, R., et al. (2009) Prognostic markers and long-term outcome of placental-site trophoblastic tumours: A retrospective observational study. Lancet, 374, 48-55. doi:10.1016/S0140-6736(09)60618-8
[12]	Shih, I.M. and Kurman, R.J. (1998) Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. The American Journal of Surgical Pathology, 22, 1393-1403. doi:10.1097/00000478-199811000-00010
[13]	Palmer, J.E., Macdonald, M., Wells, M., et al. (2008) Epithelioid trophoblastic tumor: A review of the literature. Journal of Reproductive Medicine, 53, 465-475.
[14]	International Federation of Obstetrics and Gynecology Oncology Committee (2002) FIGO staging for gestational trophoblastic neoplasia 2000. International Journal of Gynecology & Obstetrics, 77, 285-287. doi:10.1016/S0020-7292(02)00063-2
[15]	Antebi, E., Adar, R., Deutsch, V. and Mozes, M. (1974) Arteriovenous fistula complicating gynecological operations. Obstetrics and Gynaecology, 44, 858-861.
[16]	De Cockshott, P.V. and Hendrickse, J.P. (1967) Persistent arteriovenous fistulae following chemotherapy of malignnant trophoblastic disease. Radiology, 88, 329-333.
[17]	Vashisht, A., Studd, J.W., Carey, A.H., et al. (2000) Fibroid embolization: A technique not without significant complications. British Journal of Obstetrics and Gynaecology, 107, 1166-1170. doi:10.1111/j.1471-0528.2000.tb11119.x
[18]	Hare, W.S.C. and Holland, C.J. (1983) Paresis following internal iliac artery embolization. Radiology, 46, 47-51.
[19]	Lang, E.K. (1989) Management of haemorrhaging pelvic neoplasms by transcatheter embolization. Journal of Vascular and Interventional Radiology, 4, 113-117.
[20]	Lang, E.K. (1981) Transcatheter embolization of pelvic vessels for control of hemorrhage. Radiology, 140, 331-339.
[21]	Belli, A.M., Hemingway, A.P., Neal, F.E. and Millar, D.R. (1989) Arteriovenous malformation of the uterus related to trophoblastic disease: A case for surgery or embolization? Journal of Vascular and Interventional Radiology, 4, 112-118.
[22]	Chapman, D.R. and Lutz, M.H. (1985) Report of a successful delivery after nonsurgical management of a choriocarcinoma-related pelvic arteriovenous fistula. American Journal of Obstetrics & Gynecology, 153, 155-157.
[23]	McIvor, J. and Cameron, E.W. (1996) Pregnancy after uterine embolization to control haemorrhage from gestational trophoblastic tumours. British Journal of Radiology, 69, 624-629. doi:10.1259/0007-1285-69-823-624
[24]	Tham, B.W.L., Everard, J.E., Tidy, J.A., Drew, D. and Hancock, B.W. (2003) Gestational trophoblastic disease in the Asian population of Northern England and North Wales. British Journal of Obstetrics and Gynaecology, 110, 555-559. doi:10.1046/j.1471-0528.2003.01413.x
[25]	Pisal, N., Tidy, J. and Hancock, B. (2004) Gestational trophoblastic disease: Is intensive follow up essential in all women? British Journal of Obstetrics and Gynaecology, 111, 1449-1451. doi:10.1111/j.1471-0528.2004.00339.x
[26]	Sebire, N.J., Foskett, M., Short, D., Savage, P., Stewart, W., Thomson, M., et al. (2007) Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: Evidence for revised protocol of a UK regional trophoblastic disease unit. British Journal of Obstetrics and Gynaecology, 114, 760-762. doi:10.1111/j.1471-0528.2007.01320.x
[27]	Fine, C., Bundy, A.L., Berkowitz, R., Boswell, S.B., Berezin, A.F. and Doubilet, P.M. (1989) Sonographic diagnosis of partial hydatidiform mole. Obstetrics and Gynaecology, 73, 414-418.
[28]	Benson, C.B., Genest, D.R., Bernstein, M.R., Soto-Wright, V., Goldstein, D.P. and Berkowitz, R.S. (2000) Sonographic appearance of first trimester complete hydatidiform moles. Journal of Ultrasound in Obstetrics & Gynecology, 16, 188-191. doi:10.1046/j.1469-0705.2000.00201.x
[29]	Newlands, E.S. (2003) Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumours in the UK. In: Hancock, B.W., Newlands, E.S., Berkowitz, R.S. and Cole, L.A., Eds., Gestational Trophoblastic Disease. 3rd Edition, International Society for the Study of Trophoblastic Disease, London, 277-298. www.isstd.org/isstd/book.html
[30]	Woolas, R.P., Bower, M., Newlands, E.S., Seck, M.J., Short, D. and Holden, L. (1998) Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. British Journal of Obstetrics and Gynaecology, 105, 1032-1035. doi:10.1111/j.1471-0528.1998.tb10271.x